dichlorotetrakis(dimethyl sulfoxide)ruthenium II: RN given refers to parent cpd without isomeric designation, [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 150194 |
| MeSH ID | M0116445 |
| Synonym |
|---|
| dichlorotetrakis(dimethyl sulfoxide)ruthenium(ii) |
| ruthenium, dichlorotetrakis(methylsulfoxide)- |
| nsc 637822 |
| dichlorotetrakis(sulfinylbis(methane))ruthenium |
| tetrakis(dimethyl sulfoxide)ruthenium(2+) dichloride |
| dichlorotetrakis(methylsulfoxide)ruthenium |
| ruthenium, dichlorotetrakis(sulfinylbis(methane))- |
| dichlorotetrakis(dimethyl sulfoxide)ruthenium ii |
| ruthenium, dichloro(sulfinylbis(methane)-o)tris(sulfinylbis(methane)-s)-, (oc-6-22)- |
| dichlorotetrakis(dimethylsulfoxide)ruthenium(ii) |
| nsc637822 |
| 11070-19-2 |
| tetrakis(dimethylsulfoxide)dichlororuthenium (ii) |
| dichlororuthenium; methylsulfinylmethane |
| 89395-66-4 |
| tetrakis(dimethylsulfoxide)dichlororuthenium(ii) |
| DTXSID20149364 |
| mfcd00050955 |
| rucl2(dmso)4 |
| cis-tetrakis(dimethylsulfoxide)dichlororuthenium(ii) |
| UMJDEUKQHKMAOI-UHFFFAOYSA-L |
| dichlororuthenium;methylsulfinylmethane |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (7.14%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 13 (92.86%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Article | Year |
|---|---|
| Lack of In vitro cytotoxicity, associated to increased G(2)-M cell fraction and inhibition of matrigel invasion, may predict In vivo-selective antimetastasis activity of ruthenium complexes. The Journal of pharmacology and experimental therapeutics, Volume: 295, Issue: 3 | 2000 |
| Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms. European journal of cancer & clinical oncology, Volume: 20, Issue: 6 | 1984 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms. European journal of cancer & clinical oncology, Volume: 20, Issue: 6 | 1984 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |